Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 310

1.

Efficacy and safety of new oral anticoagulants for extended treatment of venous thromboembolism: systematic review and meta-analyses of randomized controlled trials.

Sardar P, Chatterjee S, Mukherjee D.

Drugs. 2013 Jul;73(11):1171-82. doi: 10.1007/s40265-013-0082-7. Review.

PMID:
23812923
2.

Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta-analysis.

van der Hulle T, Kooiman J, den Exter PL, Dekkers OM, Klok FA, Huisman MV.

J Thromb Haemost. 2014;12(3):320-8. doi: 10.1111/jth.12485. Review.

3.

Evaluation of oral anticoagulants for the extended treatment of venous thromboembolism using a mixed-treatment comparison, meta-analytic approach.

Rollins BM, Silva MA, Donovan JL, Kanaan AO.

Clin Ther. 2014 Oct 1;36(10):1454-64.e3. doi: 10.1016/j.clinthera.2014.06.033. Epub 2014 Aug 3.

PMID:
25092394
4.

Dabigatran, rivaroxaban and apixaban for extended venous thromboembolism treatment: network meta-analysis.

Alotaibi G, Alsaleh K, Wu C, Mcmurtry MS.

Int Angiol. 2014 Aug;33(4):301-8. Review.

PMID:
25056161
5.

New oral anticoagulants in elderly adults: evidence from a meta-analysis of randomized trials.

Sardar P, Chatterjee S, Chaudhari S, Lip GY.

J Am Geriatr Soc. 2014 May;62(5):857-64. doi: 10.1111/jgs.12799. Epub 2014 May 1. Review.

PMID:
24786913
6.

Comparison of the Novel Oral Anticoagulants Apixaban, Dabigatran, Edoxaban, and Rivaroxaban in the Initial and Long-Term Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis.

Cohen AT, Hamilton M, Mitchell SA, Phatak H, Liu X, Bird A, Tushabe D, Batson S.

PLoS One. 2015 Dec 30;10(12):e0144856. doi: 10.1371/journal.pone.0144856. eCollection 2015. Review.

7.

New oral anticoagulants in the treatment of acute venous thromboembolism - a systematic review with indirect comparisons.

Hirschl M, Kundi M.

Vasa. 2014 Sep;43(5):353-64. doi: 10.1024/0301-1526/a000373. Review. Erratum in: Vasa. 2014 Nov;43(6):477.

PMID:
25147012
8.
9.

Indirect treatment comparison of new oral anticoagulants for the treatment of acute venous thromboembolism.

Kang N, Sobieraj DM.

Thromb Res. 2014 Jun;133(6):1145-51. doi: 10.1016/j.thromres.2014.03.035. Epub 2014 Mar 24. Review.

PMID:
24713109
10.

Direct oral anticoagulants in the treatment of venous thromboembolism, with a focus on patients with pulmonary embolism: an evidence-based review.

Gómez-Outes A, Suárez-Gea ML, Lecumberri R, Terleira-Fernández AI, Vargas-Castrillón E.

Vasc Health Risk Manag. 2014 Nov 7;10:627-39. doi: 10.2147/VHRM.S50543. eCollection 2014. Review.

11.
12.

Do women bleed more than men when prescribed novel oral anticoagulants for venous thromboembolism? A sex-based meta-analysis.

Alotaibi GS, Almodaimegh H, McMurtry MS, Wu C.

Thromb Res. 2013 Aug;132(2):185-9. doi: 10.1016/j.thromres.2013.07.017. Epub 2013 Jul 26. Review.

PMID:
23932014
13.

Comparisons between novel oral anticoagulants and vitamin K antagonists in patients with CKD.

Harel Z, Sholzberg M, Shah PS, Pavenski K, Harel S, Wald R, Bell CM, Perl J.

J Am Soc Nephrol. 2014 Mar;25(3):431-42. doi: 10.1681/ASN.2013040361. Epub 2014 Jan 2. Review.

14.

Non-vitamin K antagonist oral anticoagulants and major bleeding-related fatality in patients with atrial fibrillation and venous thromboembolism: a systematic review and meta-analysis.

Caldeira D, Rodrigues FB, Barra M, Santos AT, de Abreu D, Gonçalves N, Pinto FJ, Ferreira JJ, Costa J.

Heart. 2015 Aug;101(15):1204-11. doi: 10.1136/heartjnl-2015-307489. Epub 2015 Jun 2. Review.

PMID:
26037103
15.

Treatment discontinuations with new oral agents for long-term anticoagulation: insights from a meta-analysis of 18 randomized trials including 101,801 patients.

Chatterjee S, Sardar P, Giri JS, Ghosh J, Mukherjee D.

Mayo Clin Proc. 2014 Jul;89(7):896-907. doi: 10.1016/j.mayocp.2014.01.030.

PMID:
24996233
16.

Comparative efficacy and safety of anticoagulants and aspirin for extended treatment of venous thromboembolism: A network meta-analysis.

Sobieraj DM, Coleman CI, Pasupuleti V, Deshpande A, Kaw R, Hernandez AV.

Thromb Res. 2015 May;135(5):888-96. doi: 10.1016/j.thromres.2015.02.032. Epub 2015 Mar 4.

PMID:
25795564
17.

Novel oral anticoagulants in patients with renal insufficiency: a meta-analysis of randomized trials.

Sardar P, Chatterjee S, Herzog E, Nairooz R, Mukherjee D, Halperin JL.

Can J Cardiol. 2014 Aug;30(8):888-97. doi: 10.1016/j.cjca.2014.04.015. Epub 2014 Apr 18. Review.

PMID:
25064581
18.
19.

Systematic review of randomized controlled trials of new anticoagulants for venous thromboembolism prophylaxis in major orthopedic surgeries, compared with enoxaparin.

Yoshida Rde A, Yoshida WB, Maffei FH, El Dib R, Nunes R, Rollo HA.

Ann Vasc Surg. 2013 Apr;27(3):355-69. doi: 10.1016/j.avsg.2012.06.010. Epub 2013 Jan 23. Review.

PMID:
23351997
20.

Risk of major bleeding in different indications for new oral anticoagulants: insights from a meta-analysis of approved dosages from 50 randomized trials.

Sardar P, Chatterjee S, Lavie CJ, Giri JS, Ghosh J, Mukherjee D, Lip GY.

Int J Cardiol. 2015 Jan 20;179:279-87. doi: 10.1016/j.ijcard.2014.11.101. Epub 2014 Nov 13.

PMID:
25464465
Items per page

Supplemental Content

Write to the Help Desk